HTRA1 and pancreatitis: Here, we highlighted the potential for inhibiting HTRA1 as a mean to impede pancreatitis-initiated PDAC, and further provided a newly discovered a small molecule drug that can inhibit HTRA1, carfilzomib, as candidate drug for PDAC therapy.